Clinical Trials Directory

Trials / Unknown

UnknownNCT05281380

VITAMin Insufficiency in Esophagogastric Neoplasms

Vitamin Insufficiency After Surgery for Esophagogastric Neoplasms: a Prospective Intervention Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
248 (estimated)
Sponsor
Zuyderland Medisch Centrum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Rationale: Esophageal cancer and gastric cancer are among the top ten most common cancers worldwide. Both diseases have major impact on the nutritional status of patients and their quality of life. Studies investigating post-operative nutritional status are limited and postoperative identification and treatment of micro- and macronutritional deficiencies are currently lacking in (inter-)national guidelines. Objective: To identify and target vitamin deficiencies after surgery for esophagogastric neoplasms. Study design: Single centre intervention study. Study population: Patients aged 18 years and older that underwent esophagectomy or (sub- )total gastrectomy for esophagogastric neoplasms. Intervention (if applicable): Two tailormade supplements for patients; one for that underwent esophagectomy and one for (sub-)total gastrectomy. Main study parameters/endpoints: Baseline micronutrient deficiency measurements and after 6, 12, 24 months supplementation,. Secondary study parameters/ endpoints: Occurrence of exocrine pancreatic insufficiency (n,%), occurrence of diarrhoea (n,%), steatorrhea (n,%), bloating (n,%), time between surgery and start of supplementation (mean in months), quality of life experienced (questionnaires) at baseline and after 6, 12, 24 months supplementation. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In this study, no health-related risks are present for participants due to the administration of supplementation that is already used as in clinical practice.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGIKAVITwo tailormade supplements for patients; one for that underwent esophagectomy and one for (sub-)total gastrectomy.

Timeline

Start date
2021-12-01
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2022-03-16
Last updated
2023-07-27

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05281380. Inclusion in this directory is not an endorsement.